Synopsis
• Analysis of opinions drawn from leading pharmaceutical industry executives.
• Provides revenue growth expectations for the period 2012-2013.
• Provides growth prospects and changes in the competitive landscape in terms of mergers and acquisitions and business structure.
• Analysis of the demand in emerging markets and growth expectations in developed countries.
• Analysis of the changing business dynamics in the pharmaceutical industry.
• Analysis of the challenges faced by buyers and suppliers.
Summary
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading pharmaceutical industry executives. It analyzes how business strategies and practices in the pharmaceutical industry are set to change in 2012-13. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.
Scope
• The opinions and forward looking statements of 247 industry executives have been captured in our in-depth survey, of which 51% represent Director and C-level respondents.
• The research is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.
• The geographical scope of the research is global - drawing on the activity and expectations of leading industry players across the Americas, Europe, Asia-Pacific, Africa and Middle East.
• This report covers data and analysis on industry developments.
• Key topics covered include threats and opportunities, economic outlook and business confidence.
• In the report, buyers identify what suppliers need to do to maintain their business and the key actions being taken by industry players to overcome the leading business threats.
• The report examines current practices and provides future expectations for the industry over the next 12-24 months.
• The report provides qualitative analysis of the key industry threats and opportunities.
Reasons To Buy
• This report will help you to drive revenues by understanding future product investment areas and growth regions.
• This report will help you to better promote your business by aligning your capabilities and business practices with your customer’s changing needs.
• This report will help you to secure stronger customer relationships by understanding the leading business concerns and changing strategies of industry buyers.
• This report will help you to predict how the industry will grow, consolidate and where it will stagnate.
• This report will help you to uncover the business outlook, key challenges and opportunities identified by suppliers and buyers.
Pharmaceutical Industry - 2012-2013
Published: June 2012 No. of Pages: 111 Price: US $ 1175
1 Introduction
1.1 What is This Report About?
1.2 Definitions
1.3 Methodology
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry
1.4.1 Profile of buyer respondents: global pharmaceutical industry
1.4.2 Profile of supplier respondents: global pharmaceutical industry
2 Executive Summary
3 Global Pharmaceutical Industry Dynamics
3.1 Revenue Growth Expectations in the Global Pharmaceutical Industry
3.1.1 Global pharmaceutical industry: revenue growth expectations by company type
3.1.2 Global pharmaceutical industry: revenue growth expectations by region
3.1.3 Global pharmaceutical industry: revenue growth expectations by turnover
3.1.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents
3.1.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons
3.2 Future Developments in Business Structure: Global Pharmaceutical Industry
3.2.1 Global pharmaceutical industry: future developments by buyers
3.2.2 Global pharmaceutical industry: future developments by suppliers
3.2.3 Global pharmaceutical industry: future developments by region
3.2.4 Global pharmaceutical industry: future developments by company turnover
3.3 M&A Activity Projections in the Global Pharmaceutical Industry
3.3.1 M&A activity projections in the global pharmaceutical industry by buyers
3.3.2 M&A activity projections in the global pharmaceutical industry by suppliers
3.3.3 M&A activity projections in the global pharmaceutical industry by region
3.3.4 M&A activity projections in the global pharmaceutical industry by company turnover
3.3.5 Global pharmaceutical industry: expansion abroad vs M&A activity projections
3.4 Capital Expenditure Forecast in the Global Pharmaceutical Industry
3.4.1 Capital expenditure forecast in the global pharmaceutical industry by buyers
3.4.2 Capital expenditure forecast in the global pharmaceutical industry by suppliers
3.4.3 Capital expenditure forecast in the global pharmaceutical industry by region
3.4.4 Capital expenditure forecast in the global pharmaceutical industry by company turnover
3.5 Planned Change in Staff Recruitment Activity: Global Pharmaceutical Industry
3.5.1 Global pharmaceutical industry: planned change in staff recruitment activity by buyers
3.5.2 Global pharmaceutical industry: planned change in staff recruitment activity by suppliers
3.5.3 Global pharmaceutical industry: planned change in staff recruitment activity by region
3.5.4 Global pharmaceutical industry: planned change in staff recruitment activity by company turnover
4 Global Pharmaceutical Industry Market Growth Outlook
4.1 Global Pharmaceutical Industry: Demand in Emerging Markets
4.1.1 Global pharmaceutical industry: demand in emerging markets by buyers
4.1.2 Global pharmaceutical industry: demand in emerging markets by suppliers
4.1.3 Global pharmaceutical industry: demand in emerging markets by region
4.1.4 Global pharmaceutical industry: demand in emerging markets by company turnover
4.2 Global Pharmaceutical Industry: Growth Expectations in Developed Countries
4.2.1 Global pharmaceutical industry: growth expectations in developed countries by buyers
4.2.2 Global pharmaceutical industry: growth expectations in developed countries by suppliers
4.2.3 Global pharmaceutical industry: growth expectations in developed countries by region
4.2.4 Global pharmaceutical industry: growth expectations in developed countries by company turnover
5 Threats and Opportunities for the Global Pharmaceutical Industry
5.1 Global Pharmaceutical Industry: Leading Business Concerns for 2012-2013
5.1.1 Global pharmaceutical industry: leading business concerns for 2012-2013 by company type
5.1.2 Global pharmaceutical industry: leading business concerns for 2012-2013 by region
5.1.3 Global pharmaceutical industry: leading business concerns for 2012-2013 by company turnover
5.2 Global Pharmaceutical Industry: Key Supplier Actions to Secure Buyer Business
5.2.1 Global pharmaceutical industry: key actions to secure buyer business (buyer respondents)
5.2.2 Global pharmaceutical industry: key actions to secure buyer business by region
5.2.3 Global pharmaceutical industry: key actions to secure buyer business by turnover
5.2.4 Global pharmaceutical industry: key actions to secure buyer business by procurement budget
5.2.5 Global pharmaceutical industry: key actions to secure buyer business by purchasing decision authority
6 Appendix
6.1 Global Pharmaceutical Industry Survey Results - Closed Questions
6.2 Methodology
6.3 Contact us
6.4 About ICD Research
6.5 Disclaimer
List of Tables
List of Figures
No comments:
Post a Comment